Search | IOVS | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Low Vision October 2015

Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010

PDF

Moncef Khairallah; Rim Kahloun; Rupert Bourne; Hans Limburg; Seth R. Flaxman; Jost B. Jonas; Jill Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A. White; Tien Y. Wong; Serge Resnikoff; Hugh R. Taylor; for the Vision Loss Expert Group of the Global Burden of Disease Study
TAGS: blindness, cataract, prevalence
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6762-6769. doi: https://doi.org/10.1167/iovs.15-17201

ARVO Annual Meeting Abstract June 2015

Blue light filtering does not modify the time course of retinal degeneration in Rd10 mice.

Javier Vicente-Tejedor; Laura Ramírez; Francisco Germaín; Pedro de la Villa; Neurophysiology/Vision group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4268. doi:

ARVO Annual Meeting Abstract June 2015

Retinal Microvascular Dysfunction occurs similarly in Alzheimer’s disease and Primary Open Angle Glaucoma patients

Stephanie Mroczkowska; Alexandra Benavente-Perez; Sunni R Patel; Anil Negi; Velota Sung; Peter Bentham; Doina Gherghel; Eye and Vision Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2763. doi:

ARVO Annual Meeting Abstract April 2014

The G-Protein Coupled Receptor P2Y2 is Upregulated in the Diabetic Rat Retina. Possible Role in Diabetic Retinopathy.

Juan E Gallo; Jorge Mancini; Gustavo Ortiz; Juan Croxatto; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1057. doi:

ARVO Annual Meeting Abstract April 2014

Accommodative versus monofocal intraocular lens implantation in cataract surgery: a systematic review of randomized controlled trials

Hon Shing Ong; Bruce D S Allan; Cochrane Eyes and Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1290. doi:

ARVO Annual Meeting Abstract April 2014

Development of a novel bio-compatible polymer film for use as a Bruch’s membrane substitute

Gareth Ward; Heather Thomson; Philip Alexander; J. Arjuna Ratnayaka; Andrew Treharne; George Attard; Martin Grossel; Andrew Lotery; Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2997. doi:

ARVO Annual Meeting Abstract April 2014

Chronological analyses of the expression of A1AT in the retina of diabetic rats

Gustavo Ortiz; Jorge Mancini; Juan Pablo Salica; Eduardo Chuluyan; Juan E Gallo; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4914. doi:

ARVO Annual Meeting Abstract April 2014

Number of People Blind or Visually Impaired or by Glaucoma Worldwide and in World Regions 1990 - 2010

Rupert Bourne; Jost B Jonas; Seth R Flaxman; Jill Keeffe; Janet Leasher; Kovin Shunmugam Naidoo; Konrad Pesudovs; Tien Y Wong; Serge Resnikoff; Hugh R Taylor; The Vision Loss Expert Group of the Global Burden of Disease Study

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4278. doi:

ARVO Annual Meeting Abstract April 2014

Number of People Blind or Visually Impaired by Diabetic Retinopathy Worldwide and in World Regions 1990 - 2010

Janet L Leasher; Jost B Jonas; Rupert Bourne; Seth R Flaxman; Jill Keeffe; Kovin Shunmugam Naidoo; Konrad Pesudovs; Tien Y Wong; Serge Resnikoff; Hugh R Taylor; Vision Loss Expert Group of the Global Burden of Disease Study 2010

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5366. doi:

ARVO Annual Meeting Abstract April 2014

Vision Impairment and Blindness due to Age-Related and other Macular Degenerations Globally: A Systematic Review and Meta-Analysis

Jill Keeffe; Jost B Jonas; Rupert Bourne; Tien Y Wong; Janet L Leasher; Kovin Shunmugam Naidoo; Holly Price; Seth R Flaxman; Serge Resnikoff; Hugh R Taylor; Global Burden of Disease Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6083. doi:

ARVO Annual Meeting Abstract April 2014

Prevalence and causes of vision loss in Sub-Saharan Africa: 1990-2010.

Kovin Shunmugam Naidoo; Stephen Gichuhi; María-Gloria Basáñez; Seth R Flaxman; Jost B Jonas; Jill Keeffe; Janet L Leasher; Konrad Pesudovs; Holly Price; Jennifer L Smith; Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6085. doi:

ARVO Annual Meeting Abstract April 2014

Prevalence and Causes of Vision Loss in North Africa and the Middle East: 1990-2010.

Moncef Khairallah; Rim Kahloun; Jost B Jonas; Jill Keeffe; Kovin Shunmugam Naidoo; Serge Resnikoff; Hugh R Taylor; Rupert Bourne; Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4159. doi:

ARVO Annual Meeting Abstract June 2013

Properties of the Dutch Reading Charts

Ger Van Rens; Tamara Verkerk Brussee; Edwin Klerkx; Ruth Nispen; Low vision group VUmc Amsterdam

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2748. doi:

ARVO Annual Meeting Abstract June 2013

Decreased Protein Expression of P2X2 in the Retina of Type 1 Diabetic Rats Treated with Suramin and PPADS

Juan Gallo; Jorge Mancini; Gustavo Ortiz; Juan Croxatto; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6323. doi:

ARVO Annual Meeting Abstract June 2013

Retinal Expression of α-1-Antitrypsin (A1AT) in diabetic and non-diabetic rats

Gustavo Ortiz; Jorge Mancini; Eduardo Chuluyan; Juan Gallo; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6329. doi:

ARVO Annual Meeting Abstract June 2013

The role of systemic infection and response to Ranibizumab therapy for Age Related Macular Degeneration (AMD)

Charles Pierce; Marie Nelson; Jennifer Scott; Helen Griffiths; Natalee James; Heather Thomson; Angela Cree; Andrew Lotery; Vision Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4105. doi:

ARVO Annual Meeting Abstract June 2013

Effects of patient traits on physician-predicted low vision outcomes

Tiffany Chan; Robert Massof; Judith Goldstein; Low Vision Research Network Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2783. doi:

ARVO Annual Meeting Abstract March 2012

Characteristics Of Randomized Trials In Ophthalmology Using A Within-person Paired Design

Roberta W. Scherer; Jennifer Breck; Ann-Margret Ervin; US Cochrane Eyes and Vision Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4734. doi:

ARVO Annual Meeting Abstract March 2012

The Global Burden of Disease Study: the Impact of Vision Loss: prevalence and trends of blindness and visual impairment over the past 28 years

Rupert R. Bourne; Gretchen Stevens; Richard A. White; Seth Flaxman; Maya Mascarenhas; Holly Price; Janet Leasher; Konrad Pesudovs; Hugh R. Taylor; GBD Study Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3175. doi:

ARVO Annual Meeting Abstract April 2011

Poloxamer Improves the Duration of Action of Suramab to Inhibit Corneal Angiogenesis

Emiliano S. Lopez; Juan Croxatto; Juan E. Gallo; Nanomedicine & Vision Group, Universidad Austral,Buenos Aires, Argentina

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6383. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010

Blue light filtering does not modify the time course of retinal degeneration in Rd10 mice.

Retinal Microvascular Dysfunction occurs similarly in Alzheimer’s disease and Primary Open Angle Glaucoma patients

The G-Protein Coupled Receptor P2Y2 is Upregulated in the Diabetic Rat Retina. Possible Role in Diabetic Retinopathy.

Accommodative versus monofocal intraocular lens implantation in cataract surgery: a systematic review of randomized controlled trials

Development of a novel bio-compatible polymer film for use as a Bruch’s membrane substitute

Chronological analyses of the expression of A1AT in the retina of diabetic rats

Number of People Blind or Visually Impaired or by Glaucoma Worldwide and in World Regions 1990 - 2010

Number of People Blind or Visually Impaired by Diabetic Retinopathy Worldwide and in World Regions 1990 - 2010

Vision Impairment and Blindness due to Age-Related and other Macular Degenerations Globally: A Systematic Review and Meta-Analysis

Prevalence and causes of vision loss in Sub-Saharan Africa: 1990-2010.

Prevalence and Causes of Vision Loss in North Africa and the Middle East: 1990-2010.

Properties of the Dutch Reading Charts

Decreased Protein Expression of P2X2 in the Retina of Type 1 Diabetic Rats Treated with Suramin and PPADS

Retinal Expression of α-1-Antitrypsin (A1AT) in diabetic and non-diabetic rats

The role of systemic infection and response to Ranibizumab therapy for Age Related Macular Degeneration (AMD)

Effects of patient traits on physician-predicted low vision outcomes

Characteristics Of Randomized Trials In Ophthalmology Using A Within-person Paired Design

The Global Burden of Disease Study: the Impact of Vision Loss: prevalence and trends of blindness and visual impairment over the past 28 years

Poloxamer Improves the Duration of Action of Suramab to Inhibit Corneal Angiogenesis

To View More...

You must be signed into an individual account to use this feature.